{"blog_url":"https://uneyama.hatenadiary.jp/","height":"190","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20080416%2Fp3\" title=\"\u6297\u751f\u7269\u8cea\u8010\u6027\uff1a\u516c\u958b\u30d2\u30e4\u30ea\u30f3\u30b0\uff1a\u610f\u898b\u52df\u96c6 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","categories":["FDA"],"url":"https://uneyama.hatenadiary.jp/entry/20080416/p3","description":"Antimicrobial Resistance; Public Hearing; Request for Comments April 15, 2008 http://www.fda.gov/OHRMS/DOCKETS/98fr/08-1129.htm 2008\u5e744\u670828\u65e5\u306b\u6297\u751f\u7269\u8cea\u8010\u6027\u306b\u95a2\u3059\u308b\u60c5\u5831\u53ce\u96c6\u306e\u305f\u3081\u306e\u516c\u958b\u30d2\u30e4\u30ea\u30f3\u30b0\u3092\u884c\u3046\u3002\u554f\u984c\u70b9\u3084\u5bfe\u5fdc\u7b56\u306a\u3069\u306b\u3064\u3044\u3066\u610f\u898b\u3092\u6c42\u3081\u3066\u3044\u308b\u3002 \u6587\u66f8\u306b\u3088\u308b\u610f\u898b\u306f2008\u5e745\u670826\u65e5\u307e\u3067\u53d7\u3051\u4ed8\u3051\u308b\u3002","title":"\u6297\u751f\u7269\u8cea\u8010\u6027\uff1a\u516c\u958b\u30d2\u30e4\u30ea\u30f3\u30b0\uff1a\u610f\u898b\u52df\u96c6","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/uneyama/","published":"2008-04-16 00:00:03","width":"100%","version":"1.0","author_name":"uneyama","type":"rich","provider_url":"https://hatena.blog","image_url":null}